| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | gossypol | CTRPv2 | pan-cancer | AAC | 0.1 | 0.008 |
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.009 |
| mRNA | Roscovitine | GDSC1000 | pan-cancer | AAC | -0.14 | 0.009 |
| mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.009 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | 0.11 | 0.009 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.077 | 0.01 |
| mRNA | CMK | GDSC1000 | pan-cancer | AAC | -0.14 | 0.01 |
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | -0.13 | 0.01 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.086 | 0.01 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.084 | 0.01 |